Skip to main navigation Skip to search Skip to main content

SAR Studies on Aromatic Acylhydrazone-Based Inhibitors of Fungal Sphingolipid Synthesis as Next-Generation Antifungal Agents

  • Krupanandan Haranahalli
  • , Cristina Lazzarini
  • , Yi Sun
  • , Julia Zambito
  • , Senuri Pathiranage
  • , J. Brian McCarthy
  • , John Mallamo
  • , Maurizio Del Poeta
  • , Iwao Ojima
  • Stony Brook University
  • VA Medical Center
  • MicroRid Technologies Inc.

Research output: Contribution to journalArticlepeer-review

37 Scopus citations

Abstract

Recently, the fungal sphingolipid glucosylceramide (GlcCer) synthesis has emerged as a highly promising new target for drug discovery of next-generation antifungal agents, and we found two aromatic acylhydrazones as effective inhibitors of GlcCer synthesis based on HTP screening. In the present work, we have designed libraries of new aromatic acylhydrazones, evaluated their antifungal activities (MIC80 and time-kill profile) against C. neoformans, and performed an extensive SAR study, which led to the identification of five promising lead compounds, exhibiting excellent fungicidal activities with very large selectivity index. Moreover, two compounds demonstrated broad spectrum antifungal activity against six other clinically relevant fungal strains. These five lead compounds were examined for their synergism/cooperativity with five clinical drugs against seven fungal strains, and very encouraging results were obtained; e.g., the combination of all five lead compounds with voriconazole exhibited either synergistic or additive effect to all seven fungal strains.

Original languageEnglish
Pages (from-to)8249-8273
Number of pages25
JournalJournal of Medicinal Chemistry
Volume62
Issue number17
DOIs
StatePublished - Sep 12 2019

Fingerprint

Dive into the research topics of 'SAR Studies on Aromatic Acylhydrazone-Based Inhibitors of Fungal Sphingolipid Synthesis as Next-Generation Antifungal Agents'. Together they form a unique fingerprint.

Cite this